eXp World (EXPI) Form 144 Filed for 80,000-Share Sale via J.P. Morgan

Rhea-AI Filing Summary

Form 144 filed for eXp World Holdings, Inc. (EXPI) reports a proposed sale of 80,000 shares of common stock through J.P. Morgan Securities LLC with an aggregate market value of $886,400 and an approximate sale date of 09/10/2025. The shares were acquired on 01/25/2021 by stock option exercise and paid for in cash on 01/27/2021. The filing discloses prior sales by the same seller during August 2025 totaling 25,000 shares for gross proceeds of $254,237 (15,000 for $154,040; 1,300 for $13,325; 8,700 for $87,872). The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Clear compliance with Rule 144 filing requirements including broker, acquisition method, and prior three-month sales
• Detailed transaction history provided: acquisition date (01/25/2021), payment in cash, and prior August 2025 sales totaling 25,000 shares
• Brokered sale through J.P. Morgan Securities LLC, indicating use of an established intermediary

Negative

• None.

Insights

Securities Analyst

TL;DR: An insider notice to sell 80,000 shares is procedural and small relative to total shares outstanding.

The Form 144 documents an insider-origin sale via a broker with clear acquisition details and recent August dispositions totaling 25,000 shares. The filing provides transparency about timing and consideration (stock option exercise paid in cash). There is no disclosure here of material nonpublic information; the filing is routine compliance for proposed restricted or control stock sales. Given outstanding shares reported, the proposed 80,000-share sale represents a modest fraction of the company's equity, suggesting limited direct impact on valuation absent other disclosures.

Corporate Governance Expert

TL;DR: Proper procedural disclosure; no governance red flags evident from the form itself.

The notice includes required elements: broker identification, acquisition date and method, past three-month sales, and seller certification regarding material information. There is no indication of a Rule 10b5-1 plan date on the form, nor is any material adverse information asserted. From a governance perspective, the form meets filing obligations and enables investors to monitor insider liquidity, but it does not by itself indicate stewardship or policy changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	80000	886400	157232312	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/25/2021	Stock Option Exercise	Issuer			80000	01/27/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Randall D. Miles C/o eXp World Holdings, Inc. 2219 Rimland Drive, Suite 301 Bellingham WA 98226	Common Stock	08/05/2025	15000	154040
Randall D. Miles C/o eXp World Holdings, Inc. 2219 Rimland Drive, Suite 301 Bellingham WA 98226	Common Stock	08/07/2025	1300	13325
Randall D. Miles C/o eXp World Holdings, Inc. 2219 Rimland Drive, Suite 301 Bellingham WA 98226	Common Stock	08/10/2025	8700	87872

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by EXPI announce?

It announces a proposed sale of 80,000 shares of EXPI common stock with an aggregate market value of $886,400 and an approximate sale date of 09/10/2025.

Who is the broker handling the proposed EXPI sale?

The sale is listed to be handled by J.P. Morgan Securities LLC at 390 Madison Avenue, New York.

How and when were the 80,000 shares being sold originally acquired?

They were acquired on 01/25/2021 by stock option exercise and payment was made in cash on 01/27/2021.

Has the seller of these EXPI shares sold any shares recently?

Yes. The seller disposed of 15,000, 1,300, and 8,700 shares on 08/05/2025, 08/07/2025, and 08/10/2025 respectively, for combined gross proceeds of $254,237.

Does the filing indicate any undisclosed material information about EXPI operations?

The signer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.